Skip to main content
ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.890
+0.110 (6.18%)
At close: Mar 9, 2026, 4:00 PM EDT
1.999
+0.109 (5.76%)
After-hours: Mar 9, 2026, 7:59 PM EDT

ProQR Therapeutics Revenue

ProQR Therapeutics had revenue of 2.92M EUR in the quarter ending September 30, 2025, a decrease of -26.78%. This brings the company's revenue in the last twelve months to 16.07M, down -12.57% year-over-year. In the year 2024, ProQR Therapeutics had annual revenue of 19.55M with 196.41% growth.

Revenue (ttm)
16.07M EUR
Revenue Growth
-12.57%
P/S Ratio
10.56
Revenue / Employee
96,773 EUR
Employees
166
Market Cap
199.10M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202419.55M12.95M196.41%
Dec 31, 20236.59M2.24M51.27%
Dec 31, 20224.36M1.98M83.31%
Dec 31, 20212.38M1.35M131.10%
Dec 31, 20201.03M-904.00K-46.77%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Heron Therapeutics 154.90M
Compugen 72.76M
Editas Medicine 46.38M
Cartesian Therapeutics 1.09M
Molecular Partners AG 856.30K
SAB Biotherapeutics 114.70K
NeOnc Technologies Holdings 59.99K
Revenue Rankings

PRQR News

More News